Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Linehan

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Cell Reports|October 10, 2019
Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune MicroenvironmentBradley N Mills, Kelli A Connolly, Jian Ye, et al.
Hepatology Communications|August 5, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapyPaul R Burchard, Luis I Ruffolo, Nicholas A Ullman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Radiation Therapy Exacerbates Tumor-Promoting Innervation and Nerve Signaling in Rectal CancerTaylor P Uccello, Maggie L Lesch, Nicholas A Ullman, et al.
The Lancet. Oncology|April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialTimothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
Cell Death & Disease|July 26, 2023
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapyTaylor P Uccello, Maggie L Lesch, Sarah A Kintzel, et al.
Annals of Surgery|January 22, 2015
Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer CollaborativeLinda X Jin, Lindsey E Moses, M Hart Squires, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypesXianlu Laura Peng, Elena V Kharitonova, Yi Xu, et al.
Molecular Therapy. Nucleic Acids|October 29, 2024
Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancerAngela L Hughson, Gary Hannon, Noah A Salama, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic CancerAngela L Hughson, Gary Hannon, Noah A Salama, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Cell Reports|October 10, 2019
Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune MicroenvironmentBradley N Mills, Kelli A Connolly, Jian Ye, et al.
Hepatology Communications|August 5, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapyPaul R Burchard, Luis I Ruffolo, Nicholas A Ullman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Radiation Therapy Exacerbates Tumor-Promoting Innervation and Nerve Signaling in Rectal CancerTaylor P Uccello, Maggie L Lesch, Nicholas A Ullman, et al.
The Lancet. Oncology|April 9, 2016
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trialTimothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, et al.
Cell Death & Disease|July 26, 2023
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapyTaylor P Uccello, Maggie L Lesch, Sarah A Kintzel, et al.
Annals of Surgery|January 22, 2015
Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer CollaborativeLinda X Jin, Lindsey E Moses, M Hart Squires, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypesXianlu Laura Peng, Elena V Kharitonova, Yi Xu, et al.
Molecular Therapy. Nucleic Acids|October 29, 2024
Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancerAngela L Hughson, Gary Hannon, Noah A Salama, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic CancerAngela L Hughson, Gary Hannon, Noah A Salama, et al.
Pageof 14